English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/221251
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Metallo-liposomes of ruthenium used as promising vectors of genetic material

AuthorsLebrón, José Antonio; Ostos, Francisco José; López-López, Manuel; Moyá, María Luisa; Sales, Carlos; García, Encarnación; García-Calderón, Clara B.; García-Calderón, Margarita; Peña-Gómez, María José; Rosado, Iván V.; Balestra, Fernando R.; Huertas Sánchez, Pablo CSIC ORCID; López-Cornejo, Pilar
KeywordsNon-toxic nanocarriers
Transfection process
Specificity by cancer cells
Gene therapy
Issue Date25-May-2020
PublisherMultidisciplinary Digital Publishing Institute
CitationPharmaceutics 12(5): 482 (2020)
AbstractGene therapy is a therapeutic process consisting of the transport of genetic material into cells. The design and preparation of novel carriers to transport DNA is an important research line in the medical field. Hybrid compounds such as metallo-liposomes, containing a mixture of lipids, were prepared and characterized. Cationic metal lipids derived from the [Ru(bpy)3]2+ complex, RuC11C11 or RuC19C19, both with different hydrophobic/lipophilic ratios, were mixed with the phospholipid DOPE. A relation between the size and the molar fraction α was found and a multidisciplinary study about the interaction between the metallo-liposomes and DNA was performed. The metallo-liposomes/DNA association was quantified and a relationship between Kapp and α was obtained. Techniques such as AFM, SEM, zeta potential, dynamic light scattering and agarose gel electrophoresis demonstrated the formation of lipoplexes and showed the structure of the liposomes. L/D values corresponding to the polynucleotide’s condensation were estimated. In vitro assays proved the low cell toxicity of the metallo-liposomes, lower for normal cells than for cancer cell lines, and a good internalization into cells. The latter as well as the transfection measurements carried out with plasmid DNA pEGFP-C1 have demonstrated a good availability of the Ru(II)-based liposomes for being used as non-toxic nanovectors in gene therapy.
Publisher version (URL)https://doi.org/10.3390/pharmaceutics12050482
URIhttp://hdl.handle.net/10261/221251
DOIhttp://dx.doi.org/10.3390/pharmaceutics12050482
E-ISSN1999-4923
Appears in Collections:(IBIS) Artículos
(CABIMER) Artículos
Files in This Item:
File Description SizeFormat 
metalomaterial.pdf6,78 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.